# A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

> **NCT05051579** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 272 (actual)

## Conditions studied

- Obesity
- Overweight and Obesity

## Interventions

- **DRUG:** LY3502970
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05051579
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-29
- **Primary completion:** 2022-08-25
- **Final completion:** 2022-11-22
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05051579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05051579, "A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05051579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*